Patents Assigned to Fondazione Piemontese per la Ricerca sul Cancro-ONLUS
  • Publication number: 20150218213
    Abstract: In one aspect, the invention relates to an inhibitor of the ?6 integrin/E-cadherin molecular complex for use as a medicament, in particular for the prevention or/and treatment of metastases of a primary cancer disease and a pharmaceutical composition or kit comprising as an active agent at least one of the inhibitors. In a further embodiment, the present invention relates to a method for determining the prognosis of metastatic homing of a primary cancer disease, in particular the aggressiveness of the metastatic potential of a primary cancer disease.
    Type: Application
    Filed: September 3, 2013
    Publication date: August 6, 2015
    Applicants: Università degli Studi di Torino, Fondazione Piemontese per la Ricerca sul Cancro-ONLUS
    Inventors: Federico Bussolino, Serena Marchiò